CSM was well represented at Irish Association for Cancer Research (IACR) Annual Meeting 2017 Newpark Hotel, Kilkenny

Among the speakers were:

Oral presentations:

Cíara Dunphy (Oral Poster Presentation)

Dr Catríona Dowling (Proffered Paper)

Dr Ian Miller (Irish Cancer Society Fellow Presentation)

Louise Walsh (Irish Cancer Society Scholar Presentation)

 

Poster Presentations:

Dr Steven Carberry

Dr Manuela Salvucci

Alessandra Di Grande

Adam Lafferty

Mariangela Meyer

 

Here are some pics

17190909_10158278731100573_2842661618371444312_n

Mariangela Meyer PhD student presenting a poster

16938537_1239061169495435_8777942304941259210_n

Alessandra Di Grande, PhD student

C5Xme_6WQAEkklP

Dr Ian Miller (Irish Cancer Society Fellow Presentation)

ANNETTE

Prof. Annette Byrne presents findings on the PDX model (Breast_Predict Investigator)

Prof Prehn in Sunday Times: Molecular test boost for bowel cancer treatment

 

Professor Jochen Prehn’s research was a focus on the Sunday Times issue 19-2-17 where he talks about how a molecular test developed at the Royal College of Surgeons in Ireland (RCSI) can predict how bowel cancer will respond to chemotherapy, ensuring that patients for whom the procedure is potentially counterproductive do not need to get the treatment.

BowelScreen, a public screening programme, can help to diagnose bowel cancers earlier than before, according to Jochen Prehn, professor of physiology and medical physics at the RCSI, who led the research team.

The test was developed when RCSI gained access to cancer tissue from 400 patients who were part of two large studies in Ireland, Europe and America of people with bowel cancer.

 

Jochen sunday times

Mini-Science TY programme 2017

Tuesday 7th February 2017: 17 transition year students from schools across Dublin are taking part in a three day interactive RCSI (Royal College of Surgeons in Ireland) Mini-Science programme, which is running from 6th – 8th February. As part of the course, students will experience life as a scientific researcher. This programme is being co-ordinated by Dr Helena Bonner in the Department of Physiology and Medical Physics at RCSI, in conjunction with the Centre for Systems Medicine, based at RCSI.

http://www.systemsmedicineireland.ie/education-and-outreach-2/education-and-outreach-2017/

Our miRNAmeConverter software is now online @omictools

An R package developed for handling naming challenges of mature miRNAs. miRNAmeConverter delivers results in a fast and transparent way. Its main functions are to check for validity of mature miRNA names, to determine the most likely miRBase version of a given set of miRNAs and to translate mature miRNA names to different versions (including sequences). A web interface enables users less familiar with R to translate miRNA names given in form of a list or embedded in text and download of the results.

https://omictools.com/mirnameconverter-tool

miRNAmeConverter

…an easy way to translate mature miRNA names to different versions.If you make use of the miRNAmeConverter please cite:
Haunsberger SJ, Connolly NMC and Prehn JHM* (2016). “miRNAmeConverter: an R/Bioconductor package for translating mature miRNA names to different miRBase versions.” Bioinformatics. doi: 10.1093/bioinformatics/btw660

Melplex events coming up in January

 

WORKSHOP “QUANTITATIVE BIOPHOTONICS FOR TRANSLATIONAL SYSTEMS BIOLOGY”

JANUARY 19, 2017JANUARY 20, 2017

The workshop will cover principles of quantitative biophotonics applications and how these can be linked to mathematical models as part of translational systems biological strategies.

Lectures are open, all welcome but places are limited!

More information here.

Print Friendly

DETAILS

Start:
January 19, 2017
End:
January 20, 2017
Event Category:
Event Tags:

VENUE

Danish Cancer Society
Copenhagen, Denmark + Google Map

Dr. Kate O’ Connor is selected to pitch her work to SFI summit

Dr. Kate Connor is a Postdoctoral Researcher in the RCSI Laboratory for Tumour Biology and Molecular Imaging directed by Dr. Annette Byrne (Senior Lecturer), in the Department of Physiology and Medical Physics. Dr. Connor is funded under an SFI Technology Innovation Development Award (TIDA) with the goal of the project to  develop a novel therapies for  a form of incurable brain cancer (glioblastoma).

Part of the TIDA award requires researchers to participate  in the SFI/EI  ‘Get Started Technology Venture Programme’ held at the esteemed DCU Ryan Academy of Entrepreneurship. This program aims to highlight the feasibility of an innovative idea for further commercial exploitation and develops awareness of entrepreneurship and the commercialisation process for researchers in the early stages of the commercialisation pipeline.

The final day of the program took place on Nov 4th with researchers presenting their work to a panel of investors and judges with the aim of highlighting the significant scientific and commercial impact of their research. Winners of this ‘dragons den’ style event have also been given the opportunity to present their pitch at the SFI Summit meeting which took place on Nov 14th in Croke Park.

Dr. Connor was among 4 other successful candidates who were chosen to present their winning pitches at the Summit next week. This event was a wonderful opportunity to showcase the project and to potentially gain investment for future work towards translation of new therapies to brain cancer patients.

Dr. Connor successfully won the popular vote of which presentation deserved further investment.

kate 1